Research.Patient.info
Hormone-refractory Prostate Cancer research hub
2 indexed studies · 1 currently recruiting
- recruitingPHASE1
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
This study is looking at a new medicine, VIR-5500, for prostate cancer that has spread and isn't responding to standard hormone therapy. It will check if the medicine is safe, how it works in the body, and if it helps shrink the cancer, both alone and with other medicines.
United States · Australia · Spain - active not recruitingPHASE2
The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
This study looks at how a drug called carboplatin works for men with advanced prostate cancer. We want to see if changes in their genes affect how well the treatment works. It could help us find better ways to treat prostate cancer in the future.
United Kingdom